PharmaJet, based in Golden, has announced that its needle-free injection system will be used to deliver approximately 1.4 million doses of polio vaccine in Nigeria. This initiative is part of a campaign targeting children under five in the Sokoto region, as the country continues to battle outbreaks of vaccine-derived poliovirus. The deployment in Nigeria follows…more
Aclarion, a healthcare technology company based in Jeffco, has announced a plan to repurchase up to $2.5 million of its common stock over the next 12 months. The Board of Directors approved this share repurchase program as part of the company’s capital allocation strategy. The timing and amount of repurchases will depend on market conditions,…more
Aclarion said it has received a U.S. patent for machine learning used to train models and predict outcomes for evaluating pain. The patent, numbered 12,601,803, covers how the company analyzes magnetic resonance spectroscopy data to help determine whether spinal discs are associated with pain. The company said its cloud-based platform converts complex spectral data into…more
Aclarion, a healthcare technology company, said it has received an award for AI Innovation in the Clinical Decision AI category for its work using artificial intelligence to help physicians identify the location of chronic low back pain. The company said the recognition is for its Nociscan solution, which uses MR spectroscopy-based biomarker analysis to help…more
Highridge Medical has entered into an exclusive distribution agreement for the United States with Waypoint Orthopedics, a Runway Healthcare portfolio company. Under the deal, Highridge will provide U.S. surgeons with Waypoint GPS, described as enabling technology intended to guide pedicle screw placement using real-time visual feedback while aiming to avoid the radiation and complexity associated…more
Aclarion, Inc. said it has signed a commercial agreement with Weill Cornell Medicine. The deal brings Nociscan to Weill Cornell Medicine and Och Spine at NewYork-Presbyterian/Weill Cornell Medical Center and to a multidisciplinary spine team led by physician and principal investigator Jaspal Ricky Singh, MD. The agreement is also tied to a study titled A…more
Jeffco-based TriSalus Life Sciences Inc. has appointed Richard Marshall as its chief medical officer on a full-time basis, effective June 29, 2026. He will move into the role from his position as medical director, which he has held since January 2025. In the new role, Marshall will lead the company’s medical strategy and provide clinical…more
Aclarion Inc. has announced a strategic dual-approach to its corporate governance and commercial growth, combining a new defensive shareholder measure with an optimistic roadmap for its AI-driven medical technology. The company board of directors has officially adopted a limited-duration stockholder rights plan. This measure is designed to protect the company and its investors from any…more
Highridge Medical, based in Westminster, has announced the limited U.S. launch of a disc designed for patients with lumbar disc degeneration. The company has completed initial surgeries at several disc replacement centers nationwide as part of this rollout. Highridge Medical collaborated with leading surgeons to facilitate the early adoption of this new treatment option, which…more
Aclarion, Inc. has published its 2026 Shareholder Letter, detailing the company’s clinical and financial strategies as it progresses through its clinical trial for treating chronic low back pain. Aclarion expects an internal readout of the 300-patient CLARITY trial by the end of Q3 and plans to publicly disclose preliminary results in Q4 of 2026. The…more
Broomfield-based Aclarion, a healthcare technology company, has completed a $10.4 million financing round at $5.18 per share. This clean capital raise significantly strengthens the company’s financial position, preserves its capital structure, and extends its operational timeline, allowing continued development of its pain identification technology. The increased capital is aimed at enhancing Aclarion’s commercialization efforts, generating…more
Aclarion, a Broomfield healthcare technology company focused on treating chronic low back pain, announced the enrollment of its first patients at two additional clinical trial sites, Northwestern Medicine and Scripps Health. This development advances the enrollment progress for its pivotal CLARITY trial. The CLARITY trial is designed to evaluate whether a new technology, Nociscan, can…more